Cervical adenocarcinoma
MONDO:0005153An adenocarcinoma arising from the cervical epithelium. It accounts for approximately 15% of invasive cervical carcinomas. Increased numbers of sexual partners and human papillomavirus (HPV) infection are risk factors. Grossly, advanced cervical adenocarcinoma may present as an exophytic mass, an ulcerated lesion, or diffuse cervical enlargement. Microscopically, the majority of cervical adenocarcinomas are of the endocervical (mucinous) type.
Also known as: adenocarcinoma - cervix, adenocarcinoma of cervix, adenocarcinoma of cervix uteri, adenocarcinoma of the cervix, adenocarcinoma of the cervix uteri, adenocarcinoma of the uterine cervix, adenocarcinoma of uterine cervix, cervical adenocarcinoma
2882 clinical trials for this condition and its sub-types, 27 tagged with Cervical adenocarcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Cervical adenocarcinoma
-
Cervical adenosquamous carcinoma 16 trials
1 sub-type
-
Cervical clear cell adenocarcinoma 4 trials
1 sub-type
-
Endocervical adenocarcinoma 3 trials
-
Wolffian duct adenocarcinoma 2 trials
-
Cervical mucinous adenocarcinoma 0 trials · 1 incl. sub-types
6 sub-types
- Endocervical type cervical mucinous adenocarcinoma 1 trial
- Cervical mucinous adenocarcinoma, minimal deviation variant 0 trials
- Cervical villoglandular adenocarcinoma 0 trials
- Intestinal variant cervical mucinous adenocarcinoma 0 trials
- Signet ring cell variant cervical mucinous adenocarcinoma 0 trials
- Uterine ligament mucinous adenocarcinoma 0 trials
-
Cervical adenoid cystic carcinoma 0 trials
-
Cervical endometrioid adenocarcinoma 0 trials
1 sub-type
-
Cervical serous adenocarcinoma 0 trials
1 sub-type
-
Uterine ligament adenocarcinoma 0 trials
4 sub-types
-
New drug cocktail aims to stop cervical cancer return
Disease control Not yet recruitingThis phase II trial tests whether adding pembrolizumab and lenvatinib to standard chemoradiation and brachytherapy can improve outcomes for adults with high-risk locally advanced cervical cancer. About 87 participants will receive the drug combination and be followed for two year…
Phase 2 • Sponsor: Prof. Dr. Remi A. Nout • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Chlorophyll-Based supplement may ease radiation damage in cervical cancer patients
Symptom relief Not yet recruitingThis phase 3 trial tests whether a daily dose of sodium-copper-chlorophyllin, a chlorophyll derivative, can reduce long-term bladder and bowel side effects from radiation therapy in 316 women with locally advanced cervical cancer. Participants take the supplement for 3 months aft…
Phase 3 • Sponsor: Tata Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Study aims to find best surgery to preserve fertility in cervical cancer patients
Knowledge-focused Not yet recruitingThis study reviews past research and hospital data to compare three types of fertility-sparing surgeries for cervical adenocarcinoma: conization, simple trachelectomy, and radical trachelectomy. The goal is to see which offers the best balance between controlling cancer and allow…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC